CITRUCEL

Manufacturer
Haleon US Holdings LLC
Effective date
2026-03-18
Label type
HUMAN OTC DRUG LABEL
Version
17
Source
full-release
Hydrated at
2026-06-01 01:50:51

Label at a glance#

ProductCITRUCEL
Active ingredientMETHYLCELLULOSE (4000 MPA.S)
Label structure15 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces a bowel movement in 12-72 hours

Dosage and administration

MIX THIS PRODUCT (CHILD OR ADULT DOSE) WITH AT LEAST 8 OUNCES (A FULL GLASS) OF WATER OR OTHER FLUID. TAKING THIS PRODUCT WITHOUT ENOUGH LIQUID MAY CAUSE CHOKING. SEE CHOKING WARNING use product at the first sign of constipation or irregularity put one dose in a full glass of cold water stir briskly and drink promptly drinking another glass of water is helpful CITRUCEL Orange Age Dose adults and children 12 years ...

Label contents#

Full prescribing information#

Active ingredient (in each heaping tablespoon) CITRUCEL Orange

OTC - ACTIVE INGREDIENT SECTION

Methylcellulose (a non-allergenic fiber) 2 g

Active ingredient (in each rounded tablespoon) CITRUCEL Sugar Free

OTC - ACTIVE INGREDIENT SECTION

Methylcellulose (a non-allergenic fiber) 2 g

Purpose

OTC - PURPOSE SECTION

Bulk-forming fiber laxative

Uses

INDICATIONS & USAGE SECTION

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 12-72 hours

Warnings

WARNINGS SECTION

Choking: taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

Ask a doctor before use if you have

OTC - ASK DOCTOR/PHARMACIST SECTION

  • a sudden change in bowel habits that persists for two weeks
  • abdominal pain, nausea, or vomiting

Stop use and ask a doctor if (CITRUCEL Orange)

OTC - STOP USE SECTION

  • constipation lasts more than 7 days
  • you have rectal bleeding
  • you fail to have a bowel movement after use
  • These may be signs of a serious condition.

Stop use and ask a doctor if (CITRUCEL Sugar Free)

OTC - STOP USE SECTION

  • constipation lasts more than 7 days
  • you have rectal bleeding
  • you fail to have a bowel movement after use
  • These could be signs of a serious condition.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • MIX THIS PRODUCT (CHILD OR ADULT DOSE) WITH AT LEAST 8 OUNCES (A FULL GLASS) OF WATER OR OTHER FLUID. TAKING THIS PRODUCT WITHOUT ENOUGH LIQUID MAY CAUSE CHOKING. SEE CHOKING WARNING
  • use product at the first sign of constipation or irregularity
  • put one dose in a full glass of cold water
  • stir briskly and drink promptly
  • drinking another glass of water is helpful

CITRUCEL Orange

Age

Dose

adults and children 12 years of age and over

start with 1 heaping tablespoon. Increase as needed, 1 heaping tablespoonat a time, up to 3 times per day.

children 6 - 11 years of age

start with 2.5 level teaspoons. Increase as needed, 2.5 level teaspoonsat a time, up to 3 times per day.

children under 6 years of age

consult a doctor

CITRUCEL Sugar Free

Age

Dose

adults and children 12 years of age and over

start with 1 rounded tablespoon. Increase as needed, 1 rounded tablespoonat a time, up to 3 times per day.

children 6 - 11 years of age

start with 2 level teaspoons. Increase as needed, 2 level teaspoonsat a time, up to 3 times per day.

children under 6 years of age

consult a doctor

Other information (Citrucel Orange)

SPL UNCLASSIFIED SECTION

  • each heaping tablespoon contains:calcium 80 mg, potassium 105 mg, sodium 10 mg
  • each heaping tablespoon contributes 60 calories from sucrose and maltodextrin
  • store below 25°C (77°F)
  • protect contents from humidity
  • keep tightly closed

Other information (Citrucel Sugar Free)

SPL UNCLASSIFIED SECTION

  • each rounded tablespoon contains:calcium 80 mg, potassium 120 mg, sodium 15 mg
  • each rounded tablespoon contributes 30 calories from maltodextrin
  • store below 25°C (77ºF)
  • protect contents from humidity
  • keep tightly closed
  • Phenylketonurics:CONTAINS PHENYLALANINE 48.6 mg per adult dose

Inactive ingredients (Citrucel Orange)

INACTIVE INGREDIENT SECTION

citric acid, dibasic calcium phosphate, FD&C yellow no. 6 lake, maltodextrin, orange flavors (natural and artificial), potassium citrate, riboflavin, soy lecithin, sucrose, titanium dioxide, tricalcium phosphate

Inactive ingredients (Citrucel Sugar Free)

INACTIVE INGREDIENT SECTION

aspartame, dibasic calcium phosphate, FD&C yellow no. 6 lake, malic acid, maltodextrin, orange flavors (natural and artificial), potassium citrate, riboflavin, soy lecithin

Questions or comments? (Citrucel Orange)

OTC - QUESTIONS SECTION

1-800-452-0051

Additional Information (CITRUCEL Orange)

SPL UNCLASSIFIED SECTION

TAMPER EVIDENT PACKAGE

DO NOT USE IF FOIL SEAL IS MISSING OR BROKEN.

GREAT TASTING

CITRUCEL

ORANGE

offers these great benefits:

  • Gentle and clinically proven effective to help relieve occasional constipation*
  • Fiber that won’t ferment to cause excess gas**
  • 100% Soluble, gluten-free, and non-allergenic fiber

*When Used As Directed.

**Based On Laboratory Testing. Individual Results May Vary.

DIRECTIONS FOR USE (NO SCOOP DOSING):

Image_pouring water_into glass.jpg
Image_pouring water_into glass.jpg

1. Fill glass with at least 8 oz. of cold water.

Image_stirring water_after Citrucel.jpg
Image_stirring water_after Citrucel.jpg

2. Measure heaping tablespoon of product (one dose) and stir product into water. Stir briskly and drink promptly.

Additional Information (CITRUCEL Sugar Free)

SPL UNCLASSIFIED SECTION

TAMPER EVIDENT PACKAGE

DO NOT USE IF FOIL SEAL IS MISSING OR BROKEN.

GREAT TASTING ORANGE FLAVOR

CITRUCEL

SUGAR FREE

offers these great benefits:

  • Gentle and clinically proven effective to help relieve occasional constipation*
  • Fiber that won’t ferment to cause excess gas**
  • 100% Soluble, gluten-free, and non-allergenic fiber

*When Used As Directed.

**Based On Laboratory Testing. Individual Results May Vary.

DIRECTIONS FOR USE (NO SCOOP DOSING):

Image_pouring water_into glass.jpg
Image_pouring water_into glass.jpg

1. Fill glass with at least 8 oz. of cold water.

Image_stirring water_after Citrucel.jpg
Image_stirring water_after Citrucel.jpg

2. Measure rounded tablespoon of product (one dose) and stir product into water. Stir briskly and drink promptly.

Principal Display Panel (CITRUCEL)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GREAT TASTE

CITRUCEL

METHYLCELLULOSE FIBER THERAPY FOR IRREGULARITY

Gentle and clinically proven effective*

  • Helps relieve occasional constipation
  • Fiber for irregularity that won’t cause excess gas**

ORANGE FLAVOR

NET WT 30 OZ (850 g)

Citrucel Orange 30 oz
Citrucel Orange 30 oz

Principal Display Panel (CITRUCEL Sugar Free)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GREAT TASTE

CITRUCEL

METHYLCELLULOSE FIBER THERAPY FOR IRREGULARITY

Gentle and clinically proven effective*

  • Helps relieve occasional constipation
  • Fiber for irregularity that won’t cause excessive gas**

SUGAR FREE

ORANGE FLAVOR

NET WT 32 OZ (907 GRAMS)

Citrucel Sugar Free 32 oz
Citrucel Sugar Free 32 oz

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1868847CITRUCEL 2 GM Powder for Oral SuspensionPSN17
1868843methylcellulose 2 GM Powder for Oral SuspensionPSN17
1868847methylcellulose 2000 MG Powder for Oral Suspension [Citrucel]SBD17
1868843methylcellulose 2000 MG Powder for Oral SuspensionSCD17
1868847Citrucel 2 GM Granules for Oral SuspensionSY17
1868847Citrucel 2 GM Powder for Oral SuspensionSY17
1868847Citrucel 2000 MG Powder for Oral SuspensionSY17
1868843methylcellulose 2 GM Granules for Oral SuspensionSY17
1868843methylcellulose 2 GM Powder for Oral SuspensionSY17

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0135-0089-692020-11-17C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-712020-11-17C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-702020-11-17C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-742020-11-17C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-752020-11-17C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-692020-09-27C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-712020-09-27C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-702020-09-27C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-742020-09-27C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-752020-09-27C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-692020-09-25C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-712020-09-25C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-702020-09-25C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-742020-09-25C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-752020-09-25C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-692020-07-22C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0089-712020-07-22C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-702020-07-22C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-742020-07-22C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts
0135-0090-752020-07-22C16284748780-1ab0e2407-27e8-f274-e053-dbdaa90a6471Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0135-0089-69CITRUCEL454 g in 1 BOTTLEPOWDER, FOR SOLUTION45417
0135-0089-71CITRUCEL850 g in 1 BOTTLEPOWDER, FOR SOLUTION85017
0135-0090-70CITRUCEL479 g in 1 BOTTLEPOWDER, FOR SOLUTION47917
0135-0090-74CITRUCEL907 g in 1 BOTTLEPOWDER, FOR SOLUTION90717
0135-0090-75CITRUCEL1191 g in 1 BOTTLEPOWDER, FOR SOLUTION119117

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0135-0089-69GM - Gram0135-00896ef4886b-287d-4d39-808c-ecab2773aa6912012-07-24
0135-0089-71GM - Gram0135-0089898fbf5c-06a8-4c13-a68e-74a65717444f12012-07-24
0135-0090-70GM - Gram0135-009000853d31-b9bc-4a2b-83fa-34968738e49d12013-02-13
0135-0090-74GM - Gram0135-00906393c8cb-0a1f-4f38-858b-174c8c8a36d512012-07-24
0135-0090-75GM - Gram0135-009073c4e040-c8cb-4aaa-a5d7-dd14cf81a71512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
METHYLCELLULOSE (4000 MPA.S)ACTIVE INGREDIENTMRJ667KA5E6
METHYLCELLULOSE (4000 MPA.S)ACTIVE MOIETYMRJ667KA5E6
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR16
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92J6
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP6
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A86
MALIC ACIDINACTIVE INGREDIENT817L1N4CKP6
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2D6
POTASSIUM CITRATEINACTIVE INGREDIENTEE90ONI6FF6
RIBOFLAVININACTIVE INGREDIENTTLM2976OFR6
SUCROSEINACTIVE INGREDIENTC151H8M5546
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP6
TRICALCIUM PHOSPHATEINACTIVE INGREDIENTK4C08XP6666

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0135-00890135-0089-69, 0135-0089-71
0135-00900135-0090-70, 0135-0090-74, 0135-0090-75

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 378 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET, COATED / ORAL333.3 mgExact identifier — unii+route
70 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii+route
154 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, LIQUID FILLED / ORAL12 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET / ORAL320 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE PELLETS / ORAL24 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, COATED / ORAL5.6 mgExact identifier — unii+route
105 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET, DELAYED RELEASE / ORAL2834 mgExact identifier — unii+route
70 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DSOLUTION / ORAL1451 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DPOWDER, FOR SUSPENSION / ORAL8000 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, FILM COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
105 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1POWDER, FOR SOLUTION / ORAL233 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, EFFERVESCENT / ORAL14404 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL42 mgExact identifier — unii+route
154 equally ranked IID candidates
RIBOFLAVINRIBOFLAVINTLM2976OFRTABLET / ORAL0.03 mgExact identifier — unii+route
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DGRANULE, FOR SUSPENSION / ORAL952 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, EFFERVESCENT / ORAL14404 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, EFFERVESCENT / ORAL14404 mgExact identifier — unii+route
105 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1POWDER, FOR SOLUTION / ORAL233 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, CHEWABLE / ORAL292 mgExact identifier — unii+route
105 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JCAPSULE / ORAL401 mgExact identifier — unii+route
70 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET / ORAL320 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, ORALLY DISINTEGRATING / ORAL12 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED / ORAL17 mgExact identifier — unii+route
154 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET, DELAYED RELEASE / ORAL2834 mgExact identifier — unii+route
70 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE / ORAL55 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, CHEWABLE / ORAL292 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED / ORAL36 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, EXTENDED RELEASE / ORAL3239 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DSUSPENSION / ORAL6040 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DPASTE / ORAL1050 mgExact identifier — unii+route
105 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8POWDER, FOR SOLUTION / ORAL40 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DFILM, SOLUBLE / ORAL19 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii+route
154 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPPOWDER, FOR SOLUTION / ORAL315 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPPOWDER, FOR SOLUTION / ORAL315 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPFILM, SOLUBLE / ORAL2 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DGRANULE, FOR SUSPENSION / ORAL952 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DFILM, SOLUBLE / ORAL19 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, COATED / ORAL49 mgExact identifier — unii+route
154 equally ranked IID candidates
SUCROSESUCROSEC151H8M554POWDER, FOR SOLUTION / ORAL38666 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET / ORAL320 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DLOZENGE / ORAL175 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE PELLETS / ORAL24 mgExact identifier — unii+route
154 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, FILM COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DPASTE / ORAL1050 mgExact identifier — unii+route
105 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DLOZENGE / ORAL175 mgExact identifier — unii+route
105 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8POWDER, FOR SOLUTION / ORAL40 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, COATED / ORAL5.6 mgExact identifier — unii+route
105 equally ranked IID candidates
MALIC ACIDMALIC ACID817L1N4CKPPOWDER, FOR SOLUTION / ORAL1230 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET / ORAL320 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE / ORAL55 mgExact identifier — unii+route
154 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8POWDER, FOR SOLUTION / ORAL40 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALIC ACIDMALIC ACID817L1N4CKPPOWDER, FOR SOLUTION / ORAL1230 mgExact identifier — unii+route+dosage form
7 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, CHEWABLE / ORAL292 mgExact identifier — unii+route
105 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii+route
154 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED PELLETS / ORAL4.4 mgExact identifier — unii+route
154 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET, FILM COATED / ORAL1075 mgExact identifier — unii+route
70 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPOWDER / ORAL2 mgExact identifier — unii+route
154 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET, EXTENDED RELEASE / ORAL360 mgExact identifier — unii+route
70 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CITRUCELMETHYLCELLULOSEHaleon US Holdings LLC9d5f2244-a610-4d45-b6e8-e79bb17a558f2026-03-18WarningsExact identifier
ndc (package): 0135-0089-71
ndc (package): 0135-0090-74
ndc (package): 0135-0089-69
ndc (package): 0135-0090-70
ndc (package): 0135-0090-75
ndc (product): 0135-0090
ndc (product): 0135-0089
ndc11 (package): 00135008969
ndc11 (package): 00135009070
ndc11 (package): 00135008971
ndc11 (package): 00135009075
ndc11 (package): 00135009074
spl id: 4d50ac6b-2405-defb-e063-6394a90aa71c
spl set id: 9d5f2244-a610-4d45-b6e8-e79bb17a558f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.